舒洛地特治疗非糖尿病性慢性肾脏病的疗效观察 |
| |
引用本文: | 秦建华,吴蔚桦,张帆,彭波. 舒洛地特治疗非糖尿病性慢性肾脏病的疗效观察[J]. 临床肾脏病杂志, 2012, 12(7): 320-322 |
| |
作者姓名: | 秦建华 吴蔚桦 张帆 彭波 |
| |
作者单位: | 四川省泸州医学院附属医院肾内科,64600泸州 |
| |
摘 要: | 目的观察舒洛地特治疗非糖尿病性慢性肾脏病(CKD)2~3期的临床疗效及安全性。方法将40例非糖尿病性CKD2~3期患者随机分为对照组和治疗组,每组20例。对照组进行常规治疗(包括降压、肠道排毒及纠正贫血等处理);治疗组在对照组治疗的基础上加服舒洛地特胶囊25mg/次,2次/d,共50d。比较2组治疗后血肌酐、24h尿蛋白定量及纤维蛋白原含量。结果治疗组血肌酐、24h尿蛋白定量及纤维蛋白原含量明显低于对照组(P〈0.05)。结论舒洛地特治疗非糖尿病性CKD2~3期效果好,具有临床应用价值。
|
关 键 词: | 肾衰竭 慢性 舒洛地特 治疗效果 |
Effects of Sulodexide in the treatment of patients with chronic kidney disease |
| |
Affiliation: | QIN Jian-hua, WU Wei- hua , ZHANG fan, et al. Department of Nephrology , the Affiliated Hospital of Luzhou Medical College,Luzhou 646000, China |
| |
Abstract: | Objective To observe the effects of Sulodexide in the treatment of chronic kidney disease (CKD). Methods Forty patients with CKD were randomly divided into control group(routine treatment) and Sulodexide-treated group(routine treatment + Sulodexide). Results The serum creatinine, 24-4 urine protein secretion and fibrinogen in Sulodexide-treated group were significantly decreased as compared with those in control group(P〈0. 05). Conclusions Sulodexide is effective in the treatment of CKD. |
| |
Keywords: | Kidney disease, Chronic Sulodexide Treatment outcome |
本文献已被 维普 万方数据 等数据库收录! |
|